Bio-Thera Solutions and Tabuk Pharmaceuticals Join Forces to Commercialize BAT2206 (Biosimilar, Stelara) in Saudi Arabia
Shots: Bio-Thera Solutions has collaborated with Tabuk Pharmaceuticals to commerci...
The US FDA Grants Approval to Celltrion's Steqeyma (Biosimilar, Stelara)
Shots: Celltrion has receive the US FDA’s approval for Steqeyma, biosimilar...
Bio-Thera Solutions and SteinCares Add Another Biosimilar, Expanding their Alliance
Shots: Bio-Thera Solutions has expanded its collaboration with SteinCares, grantin...
Celltrion Secures the CHMP’s Positive Opinion for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)...
Shots: The P-III trial of Eydenzelt vs Eylea (aflibercept) in diabetic macular ede...
Celltrion’s Omlyclo (CT-P39) Secures the Health Canada’s Approval (Biosimilar, Xolair)
Shots: The Health Canada has granted approval to Celltrion’s Omlyclo, a bios...
Biocon Biologics Reports the US FDA’s Approval of Yesintek (Biosimilar, Stelara)
Shots: The US FDA has granted approval to the company’s Yesintek, a biosimil...
